Effects of a Novel AI Mobile App on Symptom Severity in Subjects with Irritable Bowel Syndrome: A Randomized Controlled Trial

abstract: Introduction: A diet high in fermented, oligio-, di-, monosaccharide, and polyols (FODMAP) has been shown to exacerbate symptoms of irritable bowel syndrome (IBS). Previous literature has shown significant improvement in IBS symptoms after adherence to a low FODMAP diet (LFD). However,...

Full description

Bibliographic Details
Other Authors: Rafferty, Aaron (Author)
Format: Dissertation
Language:English
Published: 2020
Subjects:
Online Access:http://hdl.handle.net/2286/R.I.57197
id ndltd-asu.edu-item-57197
record_format oai_dc
spelling ndltd-asu.edu-item-571972020-06-02T03:01:19Z Effects of a Novel AI Mobile App on Symptom Severity in Subjects with Irritable Bowel Syndrome: A Randomized Controlled Trial abstract: Introduction: A diet high in fermented, oligio-, di-, monosaccharide, and polyols (FODMAP) has been shown to exacerbate symptoms of irritable bowel syndrome (IBS). Previous literature has shown significant improvement in IBS symptoms after adherence to a low FODMAP diet (LFD). However, dietary adherence to the LFD is difficult with patients stating that information provided by healthcare providers (HCPs) is generalized and nonspecific requiring them to search for supplementary information to fit their needs. Notably, studies that have used a combination of online and in-person methods for treatment have shown improved adherence to the LFD. Objective: To determine whether a novel artificial intelligence (AI) dietary mobile application will improve adherence to the LFD compared to a standard online dietary intervention (CON) in populations with IBS or IBS-like symptoms over a 4- week period. Methods: Participants were randomized into two groups: APP or CON. The intervention group was provided access to an AI mobile application, a dietary resource verified by registered dietitians which uses artificial intelligence to individualize dietary guidance in real-time with the ability to scan menus and barcodes and provide individuals with food scores based on their dietary preferences. Primary measures included mobile app engagement, dietary adherence, and manifestation of IBS-like symptoms. Baseline Results: A total of 58 participants were randomized to groups. This is an ongoing study and this thesis details the methodology and baseline characteristics of the participants at baseline and intervention start. Validation of the application could improve the range of offerings for lifestyle diseases treatable through dietary modification. Dissertation/Thesis Rafferty, Aaron (Author) Johnston, Carol (Advisor) Hall, Richard (Committee member) Fitton, Renee (Committee member) Arizona State University (Publisher) Nutrition Health sciences Artificial Intelligence Diet FODMAP Irritable Bowel Syndrome Randomized Controlled Trial Software eng 151 pages Masters Thesis Nutrition 2020 Masters Thesis http://hdl.handle.net/2286/R.I.57197 http://rightsstatements.org/vocab/InC/1.0/ 2020
collection NDLTD
language English
format Dissertation
sources NDLTD
topic Nutrition
Health sciences
Artificial Intelligence
Diet
FODMAP
Irritable Bowel Syndrome
Randomized Controlled Trial
Software
spellingShingle Nutrition
Health sciences
Artificial Intelligence
Diet
FODMAP
Irritable Bowel Syndrome
Randomized Controlled Trial
Software
Effects of a Novel AI Mobile App on Symptom Severity in Subjects with Irritable Bowel Syndrome: A Randomized Controlled Trial
description abstract: Introduction: A diet high in fermented, oligio-, di-, monosaccharide, and polyols (FODMAP) has been shown to exacerbate symptoms of irritable bowel syndrome (IBS). Previous literature has shown significant improvement in IBS symptoms after adherence to a low FODMAP diet (LFD). However, dietary adherence to the LFD is difficult with patients stating that information provided by healthcare providers (HCPs) is generalized and nonspecific requiring them to search for supplementary information to fit their needs. Notably, studies that have used a combination of online and in-person methods for treatment have shown improved adherence to the LFD. Objective: To determine whether a novel artificial intelligence (AI) dietary mobile application will improve adherence to the LFD compared to a standard online dietary intervention (CON) in populations with IBS or IBS-like symptoms over a 4- week period. Methods: Participants were randomized into two groups: APP or CON. The intervention group was provided access to an AI mobile application, a dietary resource verified by registered dietitians which uses artificial intelligence to individualize dietary guidance in real-time with the ability to scan menus and barcodes and provide individuals with food scores based on their dietary preferences. Primary measures included mobile app engagement, dietary adherence, and manifestation of IBS-like symptoms. Baseline Results: A total of 58 participants were randomized to groups. This is an ongoing study and this thesis details the methodology and baseline characteristics of the participants at baseline and intervention start. Validation of the application could improve the range of offerings for lifestyle diseases treatable through dietary modification. === Dissertation/Thesis === Masters Thesis Nutrition 2020
author2 Rafferty, Aaron (Author)
author_facet Rafferty, Aaron (Author)
title Effects of a Novel AI Mobile App on Symptom Severity in Subjects with Irritable Bowel Syndrome: A Randomized Controlled Trial
title_short Effects of a Novel AI Mobile App on Symptom Severity in Subjects with Irritable Bowel Syndrome: A Randomized Controlled Trial
title_full Effects of a Novel AI Mobile App on Symptom Severity in Subjects with Irritable Bowel Syndrome: A Randomized Controlled Trial
title_fullStr Effects of a Novel AI Mobile App on Symptom Severity in Subjects with Irritable Bowel Syndrome: A Randomized Controlled Trial
title_full_unstemmed Effects of a Novel AI Mobile App on Symptom Severity in Subjects with Irritable Bowel Syndrome: A Randomized Controlled Trial
title_sort effects of a novel ai mobile app on symptom severity in subjects with irritable bowel syndrome: a randomized controlled trial
publishDate 2020
url http://hdl.handle.net/2286/R.I.57197
_version_ 1719315784627388416